213 related articles for article (PubMed ID: 14607673)
21. Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation.
Devine SM; Newman NJ; Siegel JL; Joseph GJ; Geis TC; Schneider JA; Geller RB; Wingard JR
Bone Marrow Transplant; 1996 Sep; 18(3):569-72. PubMed ID: 8879619
[TBL] [Abstract][Full Text] [Related]
22. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Tumgor G; Arikan C; Kilic M; Aydogdu S
Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of pulmonary infection in kidney transplantation recipients taking new immunosuppressant].
Zhang YX; Yu LX; Fu SJ; Ye JS; Liu XY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1037-40. PubMed ID: 18583258
[TBL] [Abstract][Full Text] [Related]
24. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
Jain A
Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
[No Abstract] [Full Text] [Related]
25. [Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
Chen YH; Liang YX; Chen LQ; Liang JJ; Zhang J; Qiu J; Li WL; Hu JB; Xie KJ; Zhong WD; Chen LZ; Zheng KL
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2235-7. PubMed ID: 18001539
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
[TBL] [Abstract][Full Text] [Related]
28. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
29. Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy.
Sato K; Iwane T; Sekiguchi S; Nakamura A; Akamatsu Y; Kawagishi N; Miyagi S; Takeda I; Sato A; Fujimori K; Satomi S
Transplant Proc; 2009; 41(1):229-32. PubMed ID: 19249521
[TBL] [Abstract][Full Text] [Related]
30. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
[TBL] [Abstract][Full Text] [Related]
31. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
[TBL] [Abstract][Full Text] [Related]
32. FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation.
Misawa A; Takeuchi Y; Hibi S; Todo S; Imashuku S; Sawada T
Bone Marrow Transplant; 2000 Feb; 25(3):331-4. PubMed ID: 10673708
[TBL] [Abstract][Full Text] [Related]
33. Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient.
Ko WJ; Lin FL; Wang SS; Chu SH
J Heart Lung Transplant; 1997 Sep; 16(9):980-2. PubMed ID: 9322151
[No Abstract] [Full Text] [Related]
34. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
35. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft].
Shi WY; Liu T; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study.
Kondo H; Abe T; Hashimoto H; Uchida S; Irimajiri S; Hara M; Sugawara S
J Rheumatol; 2004 Feb; 31(2):243-51. PubMed ID: 14760792
[TBL] [Abstract][Full Text] [Related]
37. [Dental and oral aspects in pediatric liver transplant patients. A comparison between the effects of cyclosporine A and FK 506].
Savoldi E; Rolfi A; Majorana A; Alberti D
Minerva Stomatol; 1997 Mar; 46(3):73-7. PubMed ID: 9173223
[TBL] [Abstract][Full Text] [Related]
38. Severe cerebellar swelling and thrombotic thrombocytopenic purpura associated with FK506.
Tezcan H; Zimmer W; Fenstermaker R; Herzig GP; Schriber J
Bone Marrow Transplant; 1998 Jan; 21(1):105-9. PubMed ID: 9486505
[TBL] [Abstract][Full Text] [Related]
39. Structural skeletal impairment induced by immunosuppressive therapy in rats: cyclosporine A vs tacrolimus.
Abdelhadi M; Ericzon BG; Hultenby K; Sjöden G; Reinholt FP; Nordenström J
Transpl Int; 2002 Apr; 15(4):180-7. PubMed ID: 11976740
[TBL] [Abstract][Full Text] [Related]
40. Postural hand tremor before and following liver transplantation and immunosuppression with cyclosporine or tacrolimus in patients without clinical signs of hepatic encephalopathy.
Paul F; Müller J; Christe W; Steinmüller T; Poewe W; Wissel J
Clin Transplant; 2004 Aug; 18(4):429-33. PubMed ID: 15233821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
